Skip to content

Drug interactions

Cisplatin + Erdafitinib

Severity: Moderate

Cisplatin and Erdafitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib inhibits OCT2, a renal transporter involved in cisplatin uptake into tubular cells and elimination. The effect on cisplatin exposure and toxicity is uncertain, with a possible change in nephrotoxicity.

What this interaction means in plain words

Cisplatin and Erdafitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cisplatin belongs to Oncology; Erdafitinib belongs to Oncology.

Evidence level: Low

Why it happens

Erdafitinib inhibits OCT2 and may alter renal handling of cisplatin.

What to do

Monitor renal function and electrolytes, and watch for cisplatin toxicity. Consider dose adjustment of cisplatin based on tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cisplatin and Erdafitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cisplatin with Erdafitinib?

MediHelp rates the interaction as moderate. Cisplatin and Erdafitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib inhibits OCT2, a renal transporter involved in cisplatin uptake into tubular cells and elimination. The effect on cisplatin exposure and toxicity is uncertain, with a possible change in nephrotoxicity.

How serious is the interaction between Cisplatin and Erdafitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor renal function and electrolytes, and watch for cisplatin toxicity. Consider dose adjustment of cisplatin based on tolerability.

What other medicines interact with Cisplatin?

MediHelp also lists interactions of Cisplatin with, for example, Cidofovir, Adefovir, Adenovirus types 4 and 7 live. The full list is on the Cisplatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in